Binary toxin and its clinical importance in Clostridium difficile infection, Belgium.

about

Fidaxomicin for treatment of Clostridium difficile infection in clinical practice: a prospective cohort study in a French University Hospital.

P2860

Q39000863-867A3EBB-3B8C-45B8-B695-FA9E73AB6AE7

P2860

Binary toxin and its clinical importance in Clostridium difficile infection, Belgium.

Item

http://www.wikidata.org/entity/Q40620301

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Binary toxin and its clinical importance in Clostridium difficile infection, Belgium.

@en

type

Item

label

Binary toxin and its clinical importance in Clostridium difficile infection, Belgium.

@en

prefLabel

Binary toxin and its clinical importance in Clostridium difficile infection, Belgium.

@en

P1476

Binary toxin and its clinical importance in Clostridium difficile infection, Belgium.

@en

P2093

J Verhaegen

http://www.w3.org/2001/XMLSchema#string

V Saegeman

http://www.w3.org/2001/XMLSchema#string

P2860

Clostridium difficile strain NAP-1 is not associated with severe disease in a nonepidemic setting.

Truncation in the tcdC region of the Clostridium difficile PathLoc of clinical isolates does not predict increased biological activity of Toxin B or Toxin A

Clostridium difficile binary toxin CDT: mechanism, epidemiology, and potential clinical importance.

Prevalence and risk factors for asymptomatic Clostridium difficile carriage.

Antibiotics and hospital-acquired Clostridium difficile-associated diarrhoea: a systematic review.

The role of toxin A and toxin B in the virulence of Clostridium difficile.

Narrative review: the new epidemic of Clostridium difficile-associated enteric disease.

Binary toxin and death after Clostridium difficile infection.

Clostridium difficile ribotype does not predict severe infection.

The role of glutamate dehydrogenase for the detection of Clostridium difficile in faecal samples: a meta-analysis.

P2888

s10096-016-2719-4

P304

1741-1747

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10096-016-2719-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Marc Van Ranst

T Pilate

P577

2016-07-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1004418189

http://www.w3.org/2001/XMLSchema#string

P698

27393490

http://www.w3.org/2001/XMLSchema#string

P921

Clostridium difficile

Binary toxin and its clinical importance in Clostridium difficile infection, Belgium.

about

P2860

P2860

Binary toxin and its clinical importance in Clostridium difficile infection, Belgium.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921